Keywords
Last Name
Institution

WILLIAM E FANN

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pharmacology
Address1 Baylor Plaza
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Family and Community Medicine
    DivisionFamily & Community Medicine

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine-Hypertension

    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Psychiatry & Behavioral Sciences
    DivisionPsychiatry & Behavioral Sciences


    Collapse Additional Tools and Researcher Information 
    Collapse Aliases
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nimgaonkar VL, Sanders AR, Ganguli R, Zhang XR, Brar J, Hogge W, Fann WE, Patel PI, Chakravarti A. Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples. Am J Med Genet. 1996 Nov 22; 67(6):505-14. PMID: 8950407.
      View in: PubMed
    2. Sanders AR, Rincon-Limas DE, Chakraborty R, Grandchamp B, Hamilton JD, Fann WE, Patel PI. Association between genetic variation at the porphobilinogen deaminase gene and schizophrenia. Schizophr Res. 1993 Jan; 8(3):211-21. PMID: 8094629.
      View in: PubMed
    3. Hata T, Meyer JS, Tanahashi N, Ishikawa Y, Imai A, Shinohara T, Velez M, Fann WE, Kandula P, Sakai F. Three-dimensional mapping of local cerebral perfusion in alcoholic encephalopathy with and without Wernicke-Korsakoff syndrome. J Cereb Blood Flow Metab. 1987 Feb; 7(1):35-44. PMID: 3805163.
      View in: PubMed
    4. Hayre HS, Fann WE. An electronic model of brain damaged speech. Biomed Sci Instrum. 1987; 23:259-63. PMID: 3607181.
      View in: PubMed
    5. Ishikawa Y, Meyer JS, Tanahashi N, Hata T, Velez M, Fann WE, Kandula P, Motel KF, Rogers RL. Abstinence improves cerebral perfusion and brain volume in alcoholic neurotoxicity without Wernicke-Korsakoff syndrome. J Cereb Blood Flow Metab. 1986 Feb; 6(1):86-94. PMID: 3944220.
      View in: PubMed
    6. O'Donnell VM, Pitts WM, Fann WE. Noradrenergic and cholinergic agents in Korsakoff's syndrome. Clin Neuropharmacol. 1986; 9(1):65-70. PMID: 3548954.
      View in: PubMed
    7. Meyer JS, Tanahashi N, Ishikawa Y, Hata T, Velez M, Fann WE, Kandula P, Mortel KF, Rogers RL. Cerebral atrophy and hypoperfusion improve during treatment of Wernicke-Korsakoff syndrome. J Cereb Blood Flow Metab. 1985 Sep; 5(3):376-85. PMID: 4030916.
      View in: PubMed
    8. Fann WE, Moreira AF. Neuroleptic bioequivalency: tablet versus concentrate. J Clin Pharmacol. 1985 May-Jun; 25(4):305-6. PMID: 2861214.
      View in: PubMed
    9. Fann WE, Lyle FA, Higginbotham W. Nomifensine vs. imipramine in depressed inpatients. J Clin Psychiatry. 1984 Apr; 45(4 Pt 2):60-2. PMID: 6370978.
      View in: PubMed
    10. Faulkner RD, Pitts WM, Lee CS, Lewis WA, Fann WE. Multiple-dose doxepin kinetics in depressed patients. Clin Pharmacol Ther. 1983 Oct; 34(4):509-15. PMID: 6617074.
      View in: PubMed
    11. Nevlud GN, Fann WE, Falck F. Acoustic parameters of voice and neuroleptic medication. Biol Psychiatry. 1983 Sep; 18(9):1081-4. PMID: 6139130.
      View in: PubMed
    12. Pitts WM, Fann WE, Sajadi C, Snyder S. Alprazolam in older depressed inpatients. J Clin Psychiatry. 1983 Jun; 44(6):213-5. PMID: 6133850.
      View in: PubMed
    13. Campbell RJ, Fann WE, Thornby JI. Abnormal involuntary movements and chronic obstructive pulmonary disease. J Clin Psychopharmacol. 1983 Jun; 3(3):179-82. PMID: 6135722.
      View in: PubMed
    14. Pitts WM, Fann WE, Halaris AE, Dressler DM, Sajadi C, Snyder S, Ilaria RL. Bupropion in depression: a tri-center placebo-controlled study. J Clin Psychiatry. 1983 May; 44(5 Pt 2):95-100. PMID: 6406473.
      View in: PubMed
    15. Fann WE, Garcia J, Richman BW. High-dose benzodiazepine therapy in hospitalized anxious patients. J Clin Pharmacol. 1983 Feb-Mar; 23(2-3):100-5. PMID: 6133884.
      View in: PubMed
    16. Fann WE, Pitts WM, Wheless JC. Pharmacology, efficacy, and adverse effects of halazepam, a new benzodiazepine. Pharmacotherapy. 1982 Mar-Apr; 2(2):72-9. PMID: 6152591.
      View in: PubMed
    17. Garland WA, Muccino RR, Min BH, Cupano J, Fann WE. A method for the determination of amitriptyline and its metabolites nortriptyline, 10-hydroxyamitriptyline, and 10-hydroxynortriptyline in human plasma using stable isotope dilution and gas chromatography-chemical ionization mass spectrometry (GC-CIMS). Clin Pharmacol Ther. 1979 Jun; 25(6):844-56. PMID: 376209.
      View in: PubMed
    18. Fann WE, Wheless JC. Dangers of psychotropic polypharmacy. Curr Psychiatr Ther. 1978; 18:143-54. PMID: 380925.
      View in: PubMed
    19. Stafford JR, Fann WE. Deanol acetamidobenzoate (Deaner) in tardive dyskinesia. Dis Nerv Syst. 1977 Dec; 38(12 Pt 2):3-6. PMID: 590063.
      View in: PubMed
    20. Fann WE, Wheless JC, Richman BW. Treating the aged with psychotropic drugs. Gerontologist. 1976 Aug; 16(4):322-8. PMID: 1026574.
      View in: PubMed
    21. Fann WE. Pharmacotherapy in older depressed patients. J Gerontol. 1976 May; 31(3):304-10. PMID: 5482.
      View in: PubMed
    22. Fann WE, Sussex JN. Late effects of early dependency need deprivation: the meal ticket syndrome. Br J Psychiatry. 1976 Mar; 128:262-8. PMID: 1252691.
      View in: PubMed
    23. Fann WE, Sullivan JL, Miller RD, McKenzie GM. Deanol in tardive dyskinesia: a preliminary report. Psychopharmacologia. 1975 May 28; 42(2):135-7. PMID: 1161974.
      View in: PubMed
    24. Fann WE, Lake CR, Richman BW. Drug induced parkinsonism. A re-evaluation. Dis Nerv Syst. 1975 Feb; 36(2):91-3. PMID: 1116421.
      View in: PubMed
    25. Fann WE, Sullivan JL, Miller RD. Halazepam in anxious outpatients: a controlled study. Curr Ther Res Clin Exp. 1974 Dec; 16(12):1281-6. PMID: 4156291.
      View in: PubMed
    26. Fann WE, Lake CR, McKenzie GM. Proceedings: Adrenergic anc cholinergic factors in extrapyramidal disorders. Psychopharmacol Bull. 1974 Jul; 10(3):52-3. PMID: 4419306.
      View in: PubMed
    27. Fann WE, Lake CR. On the coexistence of parkinsonism and tardive dyskinesia. Dis Nerv Syst. 1974 Jul; 35(7):324-6. PMID: 17894090.
      View in: PubMed
    28. Fann WE, Lake CR, Gerber CJ, McKenzie GM. Cholinergic suppression of tardive dyskinesia. Psychopharmacologia. 1974 Jun 21; 37(4):101-7. PMID: 4367406.
      View in: PubMed
    29. Fann WE, Davis JM, Janowsky DS, Kaufmann JS, Cavanaugh JH, Oates JA. Effect of antidepressant and antimanic drugs on amine uptake in man. J Nerv Ment Dis. 1974 May; 158(5):361-8. PMID: 4596092.
      View in: PubMed
    30. Lake CR, Fann WE. Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. Br J Psychiatry. 1973 Nov; 123(576):523-5. PMID: 4766648.
      View in: PubMed
    31. Fann WE, Davis JM, Wilson IC. Methylphenidate in tardive dyskinesia. Am J Psychiatry. 1973 Aug; 130(8):922-4. PMID: 4577471.
      View in: PubMed
    32. Fann WE. Some clinically important interactions of psychotropic drugs. South Med J. 1973 Jun; 66(6):661-5. PMID: 4145346.
      View in: PubMed
    33. Fann WE, Gerber CJ, McKenzie GM. Physostigmine in rigid Huntington's disease. Confin Neurol. 1973; 35(5):312-5. PMID: 4271422.
      View in: PubMed
    34. Fann WE, Linton PH. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint. Curr Ther Res Clin Exp. 1972 Aug; 14(8):478-82. PMID: 4629310.
      View in: PubMed
    35. el-Yousef MK, Davis JM, Janowsky DS, Fann WE. Central atropine-like toxicity in combined psychotropic drug administration. J Tenn Med Assoc. 1972 Aug; 65(8):719. PMID: 4152620.
      View in: PubMed
    36. Janowsky DS, el-Yousef MK, Davis JM, Fann WE, Oates JA. Guanethidine antagonism by antipsychotic drugs. J Tenn Med Assoc. 1972 Jul; 65(7):620-2. PMID: 4671681.
      View in: PubMed
    37. Fann WE, Davis JM, Janowsky DS, Kaufmann JS, Griffith JD, Oates JA. Effect of iprindole on amine uptake in man. Arch Gen Psychiatry. 1972 Feb; 26(2):158-62. PMID: 5060401.
      View in: PubMed
    38. Janowsky DS, Davis JM, Fann WE, Freeman J, Nixon R, Michelakis AA. Angiotensin effect on uptake of norepinephrine by synaptosomes. Life Sci I. 1972 Jan 1; 11(1):1-11. PMID: 4347214.
      View in: PubMed
    39. Fann WE, Davis JM, Janowsky DS, Cavanaugh JH, Kaufmann JS, Griffith JD, Oates JA. Effects of lithium on adrenergic function in man. Clin Pharmacol Ther. 1972 Jan-Feb; 13(1):71-7. PMID: 5008194.
      View in: PubMed
    40. Davis JM, Fann WE. Lithium. Annu Rev Pharmacol. 1971; 11:285-302. PMID: 4948500.
      View in: PubMed
    41. Held JM, Cromwell RL, Frank ET, Fann WE. Effect of phenothiazines on reaction time in schizophrenics. J Psychiatr Res. 1970 Feb; 7(3):209-13. PMID: 5440861.
      View in: PubMed
    42. Oates JA, Fann WE, Cavanaugh JH. Effect of doxepin on the norepinephrine pump. A preliminary report. Psychosomatics. 1969 May-Jun; 10(3):12-3. PMID: 5822695.
      View in: PubMed
    43. Fann WE. Use of methylphenidate to counteract acute dystonic effects of phenothiazines. Am J Psychiatry. 1966 May; 122(11):1293-4. PMID: 5909462.
      View in: PubMed
    FANN's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _